In this study, we firstly evaluated the expression of IGF1R, EGFR and its signaling protein expression in human adrenocortical tumors, then investigated the crosstalk between EGFR and IGF1R pathway, and confirmed the therapeutic effect of co-inhibition of EGFR and IGF1R in ACC. The gene discussed is IGF1R; the disease is adrenal cortex carcinoma.